How many shares of ZNTL does D. E. Shaw & Co., Inc. own?

As of 2026-Q2, D. E. Shaw & Co., Inc. holds 546,566 shares of ZNTL (ZENTALIS PHARMACEUTICALS INC).

What is D. E. Shaw & Co., Inc.'s ZNTL position worth?

As of 2026-Q2, D. E. Shaw & Co., Inc.'s ZNTL position is worth $2.7M.

In 2026-Q2, D. E. Shaw & Co., Inc. decreased their ZNTL position (-63.2% change in shares).

Based on available 13F filings, D. E. Shaw & Co., Inc. first reported a position in ZNTL in 2020-Q2. They have held the position across 23 quarters.

Position history for DED. E. Shaw & Co., Inc.'s holdings in ZENTALIS PHARMACEUTICALS INC

Current Value

$2.7M

Current Shares

546,566

Total Value Change

+$1.5M

Total Shares Change

+521,631

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	546,566	-63.2%	$2.7M	0.0%	$4.85	0
2026-Q1	Decreased	1.5M	-10.6%	$3.5M	0.0%	$2.38	0
2025-Q4	Increased	1.7M	+17.9%	$2.2M	0.0%	$1.33	30
2025-Q3	Increased	1.4M	+17.6%	$2.1M	0.0%	$1.49	30
2025-Q2	Increased	1.2M	+7.1%	$1.4M	0.0%	$1.18	27
2025-Q1	Decreased	1.1M	-9.8%	$1.8M	0.0%	$1.81	0
2024-Q4	Increased	1.2M	+9.8%	$3.8M	0.0%	$2.92	29
2024-Q3	Increased	1.1M	+369.6%	$4.2M	0.0%	$3.75	43
2024-Q2	Increased	240,341	+1581.8%	$982,995	0.0%	$4.09	40
2024-Q1	New	14,291	-	$225,226	0.0%	$15.76	32
2023-Q4	Exited	0	-100.0%	$0	0.0%	$15.15	0
2023-Q3	New	37,439	-	$751,026	0.0%	$20.06	34
2022-Q4	Exited	0	-100.0%	$0	0.0%	$20.14	0
2022-Q3	Decreased	29,112	-46.8%	$631,000	0.0%	$21.48	0
2022-Q2	Increased	54,745	+161.2%	$1.5M	0.0%	$27.14	41
2022-Q1	Increased	20,959	+15.8%	$967,000	0.0%	$45.58	29
2021-Q4	Decreased	18,092	-66.8%	$1.5M	0.0%	$82.68	0
2021-Q3	Decreased	54,438	-3.6%	$3.6M	0.0%	$61.48	0
2021-Q2	Increased	56,454	+154.6%	$3M	0.0%	$53.19	43
2021-Q1	Decreased	22,171	-51.0%	$962,000	0.0%	$40.31	0
2020-Q4	Increased	45,287	+466.6%	$2.4M	0.0%	$55.70	42
2020-Q3	Decreased	7,993	-67.9%	$261,000	0.0%	$33.42	0
2020-Q2	New	24,935	-	$1.2M	0.0%	$45.47	35

Other major holders of ZNTL: VIKING GLOBAL INVESTORS LP